- Home
- VYNE vs IDAI Comparison
VYNE vs IDAI Comparison
Compare VYNE & IDAI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- VYNE
- IDAI
- Stock Information
- Founded
- VYNE 2003
- IDAI 2016
- Country
- VYNE United States
- IDAI United States
- Employees
- VYNE N/A
- IDAI N/A
- Industry
- VYNE Biotechnology: Pharmaceutical Preparations
- IDAI Computer Software: Prepackaged Software
- Sector
- VYNE Health Care
- IDAI Technology
- Exchange
- VYNE Nasdaq
- IDAI Nasdaq
- Market Cap
- VYNE 7.9M
- IDAI 7.7M
- IPO Year
- VYNE 2018
- IDAI N/A
- Fundamental
- Price
- VYNE $0.30
- IDAI $2.98
- Analyst Decision
- VYNE Buy
- IDAI
- Analyst Count
- VYNE 2
- IDAI 0
- Target Price
- VYNE $8.00
- IDAI N/A
- AVG Volume (30 Days)
- VYNE 1.9M
- IDAI 23.5K
- Earning Date
- VYNE 11-06-2025
- IDAI 08-14-2025
- Dividend Yield
- VYNE N/A
- IDAI N/A
- EPS Growth
- VYNE N/A
- IDAI N/A
- EPS
- VYNE N/A
- IDAI N/A
- Revenue
- VYNE $476,000.00
- IDAI $3,366,415.00
- Revenue This Year
- VYNE N/A
- IDAI $25.13
- Revenue Next Year
- VYNE N/A
- IDAI $48.09
- P/E Ratio
- VYNE N/A
- IDAI N/A
- Revenue Growth
- VYNE N/A
- IDAI N/A
- 52 Week Low
- VYNE $0.29
- IDAI $1.43
- 52 Week High
- VYNE $4.30
- IDAI $18.75
- Technical
- Relative Strength Index (RSI)
- VYNE 28.46
- IDAI 54.65
- Support Level
- VYNE $0.32
- IDAI $2.71
- Resistance Level
- VYNE $0.33
- IDAI $3.08
- Average True Range (ATR)
- VYNE 0.02
- IDAI 0.17
- MACD
- VYNE 0.03
- IDAI 0.01
- Stochastic Oscillator
- VYNE 11.44
- IDAI 73.96
About VYNE VYNE Therapeutics Inc.
VYNE Therapeutics Inc is a biopharmaceutical company focused on developing proprietary, innovative and differentiated therapies for the treatment of immuno-inflammatory conditions. Its advanced product candidate is FMX114, which is being evaluated for the potential treatment of mild-to-moderate AD (atopic dermatitis). The company is also in the pre-clinical stages of developing products containing BET (Bromodomain and Extra-Terminal Domain) inhibitor compounds. Its products include AMZEEQ, ZILXI, and FCD105.
About IDAI T Stamp Inc.
T Stamp Inc develops and markets identity authentication software solutions for enterprise partners and peer-to-peer markets. The company is engaged in developing proprietary artificial intelligence-powered solutions; researching and leveraging biometric science, cryptography, and data mining to deliver insightful identity & trust predictions while identifying and defending against fraudulent identity attacks, protecting sensitive user information, and extending the reach of digital services through accessibility. The artificial intelligence-powered solutions segment generates revenue principally from software licenses, professional services, and recurring Software-as-a-Service ("SaaS") revenue.